KAM
AGN

Knightsbridge Asset Management’s Allergan Inc AGN Stock Holding History

Knightsbridge Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,900
Closed -$617K – 55
2014
Q4 		$617K Buy
+2,900
New +$577K 0.2% 35
2014
Q3 		– Sell
-2,900
Closed -$491K – 51
2014
Q2 		$491K Sell
2,900
-1,600
-36% -$249K 0.13% 36
2014
Q1 		$558K Sell
4,500
-500
-10% -$60.9K 0.15% 33
2013
Q4 		$555K Hold
5,000
– – 0.15% 35
2013
Q3 		$452K Hold
5,000
– – 0.11% 39
2013
Q2 		$421K Buy
+5,000
New +$519K 0.1% 38

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Knightsbridge Asset Management's AGN Position: Q1 2015 in Review

Knightsbridge Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,900 shares — an estimated $617K sold.

Knightsbridge Asset Management first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $617K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Knightsbridge Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Knightsbridge Asset Management sold 2,900 Allergan Inc shares in Q1 2015, an estimated $617K.
  • Knightsbridge Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Knightsbridge Asset Management's Allergan Inc position peaked at $617K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Knightsbridge Asset Management's 13F filing for Q1 2015, filed 15 May 2015.